Semaglutide is a GLP-1 receptor agonist indicated for type 2 diabetes and weight management. Administer subcutaneously under clinical supervision. Monitor glucose and other metabolic parameters.

Semaglutide is a GLP-1 receptor agonist indicated for type 2 diabetes and weight management. Administer subcutaneously under clinical supervision. Monitor glucose and other metabolic parameters.